Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors
Strategic collaboration aims to facilitate the manufacturing of UW–Madison's internally developed CAR-T investigational therapy
Partnership seeks to address cell therapy manufacturing bottlenecks and accelerate development towards clinical trials
Clinical scale manufacturing of cell therapy assets provides latest validation of Cell Shuttle's ability to empower partners to seamlessly scale production
SAN FRANCISCO & MADISON, Wis., April 10, 2025--(BUSINESS WIRE)--Cellares, the pioneering Integrated Development and Manufacturing Organization (IDMO), has announced a strategic collaboration with the University of Wisconsin School of Medicine and Public Health to automate the manufacturing of a CRISPR-edited GD2 CAR-T investigational therapy.
Cellares' Cell Shuttle™ supports early-phase biotechnology and academic cell therapy developers by providing an integrated, automated solution enabling immediate economies of scale and up to 50% lower batch prices compared to conventional CDMOs. As cell therapy assets mature, the platform ensures a seamless transition from clinical development to commercial-scale manufacturing, eliminating the need for costly process redesigns and multiple technology transfers and accelerating time-to-market for innovative therapies.
The collaboration highlights Cellares' commitment to empowering principal investigators and researchers in academic institutions by providing access to an automated, reproducible, and scalable manufacturing platform at the earliest stages of clinical development. By leveraging the Cell Shuttle's ability to simultaneously manufacture multiple cell therapy products in parallel, this partnership overcomes longstanding manufacturing bottlenecks caused by limited manufacturing capacity.
This approach shortens the journey from proof-of-concept in the lab to an investigational therapy suitable for clinical trials, ultimately aiming to improve care for patients with solid tumors. It also demonstrates how the Cell Shuttle is an automated solution for cell therapy developers of all stages, allowing them to seamlessly scale up as their manufacturing needs evolve.
"Solid tumors can be challenging to treat, and many patients have limited therapeutic options," said Fabian Gerlinghaus, Co-founder and CEO of Cellares. "By collaborating with researchers at the University of Wisconsin–Madison on their CRISPR-edited GD2 CAR-T product, we remove the manufacturing barriers that can hinder promising research. Our Cell Shuttle automates and scales production to a clinical level, which accelerates the transition from academic innovation to investigational therapy and brings hope to those who need new treatment options."
By enabling the CRISPR-edited GD2 CAR-T project at University of Wisconsin–Madison to achieve clinical-scale manufacturing earlier, the partnership can help unlock potential investment into the experimental therapy and expedite its path to initial human trials. The Cell Shuttle automates key steps that traditionally slow down development, thus enabling life-saving discoveries to advance more quickly.
Cellares encourages collaboration with researchers, academic institutions, and commercial partners at all stages of their projects, demonstrating its unwavering commitment to advancing the field of cell therapy and expanding patient access to next-generation treatments. For more information on the Cell Shuttle and Cellares' scalable manufacturing solutions, please visit cellares.com.
About University of Wisconsin School of Medicine and Public Health
The University of Wisconsin School of Medicine and Public Health is recognized as one of the nation's leading institutions in health sciences education, research, and service. Founded in 1907 as the medical school of the University of Wisconsin–Madison, in 2005 it became the nation's first school to integrate the disciplines of medicine and public health. With a deep commitment to a vision of healthy people and healthy communities, we translate discovery into application and interconnect clinical care, education and research. The school employs more than 5,400 faculty and staff and provides educational opportunities for nearly 2,400 students and postgraduate trainees. Grants awarded to School of Medicine and Public Health principal investigators in fiscal year 2023 totaled $641 million in federal and non-federal awards. Some of the nation's leading researchers, educators, and clinicians are among the faculty, including several National Medal of Science recipients and National Academy of Science honorees. For more information, visit med.wisc.edu.
About Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company's Cell Shuttle™ integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. While the Cell Shuttle™ automates cell therapy manufacturing, the Cell Q™ automates quality control at high throughput, both for in-process and batch release QC, addressing both manufacturing and QC bottlenecks. Cell Shuttles and Cell Qs will be deployed in Cellares' IDMO Smart Factories around the world, enabling each Smart Factory to produce 10 times as many cell therapy batches as conventional CDMOs with the same facility size and number of employees. Partnering with Cellares enables academic medical centers, biotechnology companies, and pharmaceutical companies to accelerate cell therapy development, scale-out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its first commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. Cellares is building a global network of IDMO Smart Factories with additional facilities under construction in Europe and Japan. The company is backed by world-class investors and has raised over $355 million in financing.
For more information about Cellares, please visit cellares.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250410396952/en/
Contacts
Cellares Contacts
Investors:ir@cellares.com
Media:pr@cellares.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
5 hours ago
- USA Today
Summer kicks off with a new corporate perk aimed to ease employees' stress
Summer kicks off with a new corporate perk aimed to ease employees' stress Companies looking to ease employees' stress over the summer are offering a new perk -- discounted summer camp and childcare. Show Caption Hide Caption More men are becoming family caregivers Men face a unique set of challenges when it comes to stepping into the role of a caregiver. Kids might be excited about the end of the school year and for summer to begin, but many working parents who don't know how to fill their kids' long summer days may be feeling some dread right about now. AT&T is trying to change that. The third largest U.S. wireless carrier is launching an onsite summer camp at its Dallas, Texas, headquarters in June to give its employees more convenient options for reliable childcare during the school break. Childcare outranked any other perk including mental health support, paid maternity/paternity leave and tuition reimbursements as a benefit employers aimed to offer their workers last year, according to a survey of corporate-suite and human resource leaders. One in 5 employees said they had left a job because their employer didn't provide family care benefits, and a lack of childcare benefits topped the list of reasons they sought another job. 'The summer camp was in response to specific asks and pain points our employees had,' said Matt Phillips, AT&T assistant vice president of benefits. But childcare isn't the only caregiving people ask for nowadays, he said. People want help caring for every important person, or sometimes pet, in their lives, he said. What's different about summer? 'When planning vacations and summer activities, there may be days sporadically that fall throughout the summer when people need some childcare,' Phillips said. To help ease worries of what to do with kids on those days, AT&T employees can register their children ages 4-12 for the 10-week onsite camp that runs weekdays from 8 a.m. to 6 p.m. Families have the flexibility to book one or multiple days whenever they'd like throughout the summer. There's no weekly sessions or commitments required. If employees use their backup care benefits, a day of camp would cost $15 for one child or $25 for two or more children. AT&T backup care allow workers up to 10 days of subsidized childcare if their primary care option is unavailable, and they can't take time off. They can choose center care for $15 per day or in-home care with a Bright Horizons caregiver for $4 an hour. Bright Horizons runs childcare centers and early education services nationwide. Additional days of summer camp can be bought at a discounted rate. Tell us: The caregiving crisis is real. USA TODAY wants to hear from you about how to solve it. What are other types of caregiving? Caregiving has typically meant childcare, but the COVID-19 pandemic, an aging population and rising costs have expanded the definition to include siblings, parents, grandparents and even pets. Gen Z through Gen X and even some of the youngest members of the Baby Boomers who expect to retire soon are demanding personalized benefits beyond retirement funds, salary and vacation days. Job seekers, even those fresh out of school, now have a 'holistic outlook,' said Blayre Riley, 22. 'We're not just looking at salary.' Riley doesn't have kids, but she has a 6-year-old kid brother. Her job benefits allow her to use so-called caregiver days, which are paid hours she can use to take care of a sick friend, relative or other loved one or take them to appointments, for example. With these benefits, if her little brother 'has a class party, I can go in the morning and come back to work in the afternoon, and it doesn't feel like a burden to my team,' Riley said. 'Or if he has a day off school and my parents work, I can spend time with him.' 'My dad always talks about when I was younger, his job didn't have this flexibility and when my mom was sick, he couldn't take her to doctor's appointments,' she added. 'Now, my job has it, and it can exist for everyone.' Education help: College applications are stressful. Here's how more companies are helping. New perks: Some workers are job hopping for fertility benefits. Employers are trying to keep up. What's at stake? The lack of available childcare alone costs the economy $122 billion every year, according to a 2023 study from the bipartisan Council for a Strong America. Yet, just 12% of all U.S. workers have access to childcare benefits through their employer, and only 6% of those who work part-time or in the lowest income quartile do, according to a Boston Consulting Group study published last year. Family caregivers ages 50 and older who leave the workforce to care for a parent lost $303,880, on average, in income and benefits over a caregiver's lifetime, according to a 2016 Families Caring for an Aging America study. The breakdown was as follows: $115,900 in lost wages, $137,980 in lost Social Security benefits, and conservatively $50,000 in lost pension benefits. Still, only 13% of companies offer eldercare referral services, and just 1% of companies offer employees subsidies for eldercare, according to SHRM's 2024 Employee Benefits Survey. Lack of support leads to caregiver burnout. Half of caregivers said caregiving increased their level of emotional stress, while 37% said it impacted their physical feelings of stress according to a 2023 AARP survey. What can companies do? Companies 'must address new needs, particularly around things like caregiving benefits, absence and leave benefits, and wellness benefits in all forms, as well as personalizing/customizing benefits to keep their workers happy,' said Bryan Hodgens, head of research at Life Insurance Management Research Association, or LIMRA, in a report. Comprehensive caregiving benefits like flexible work arrangements, paid leave, financial support, and access to education, consultations, resources, and digital caregiving platforms can improve workers' wellbeing and boost businesses. BCG found that childcare benefits alone deliver returns of up to 425% of their cost for companies across the U.S. Aside from caregiving, it's imperative companies also offer employees opportunities for self-care. Healthier habits help keep healthcare costs down for both employees and employers. AT&T, for example, offers a Wellbeing Choice Account to reward employees for healthy habits. Employees and their partners or spouses can each earn up to $750 annually for completing wellness activities like getting their annual physical. They can then use that money to go towards fitness classes, an exercise bike, student loan repayment, massages and facials, and healthy meal kits. 'It's like free money because you're getting paid to do things you should be doing anyway,' said Ryan Stafford, an AT&T employee who used his rewards to buy a nicer bike than he would have been able to afford. 'l had no guilt spending a little more,' he said. Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday.
Yahoo
14 hours ago
- Yahoo
Hackers leak 86 million AT&T customer records with 44 million social security numbers, report says
If you are one of the more than 100 million people who use AT&T, you might want to take stock of your data. Hackers said they accessed and leaked millions of AT&T customers' private information after the ShinyHunters group allegedly stole the data in April 2024, according to a new report from Hack Read. The report claimed some 86 million AT&T customer records have been leaked, including full names, dates of birth, phone numbers, email addresses, physical addresses, and social security numbers. In total, Hack Read reported that 44 million social security numbers were included in the leaked data. The social security numbers and birth dates were encrypted in the original hack by the ShinyHunters group, a leak that was made possible by security flaws in the Snowflake cloud data platform, as Mashable previously reported. Now, Hack Read has reported that this sensitive data is now decrypted. We asked AT&T about the reported leak of their customer data. An AT&T spokesperson told Mashable in a statement that "it is not uncommon for cybercriminals to re-package previously disclosed data for financial gain." "We are aware of claims that AT&T data is being made available for sale on dark web forums, and we are conducting a full investigation," the spokesperson added. So, if you're an AT&T customer, this means your valuable private data could be part of this new leak. However, if your data was exposed in this leak, it was likely — although not certainly — already exposed in the August 2024 National Public Data breach. Mashable previously reported on this breach, which exposed "three decades' worth of Social Security numbers on the online black market." You can find out if your data was exposed in that breach by using a tool from Pentester, a cybersecurity firm, to check. Visit enter your information, and see your list of breached accounts.
Yahoo
17 hours ago
- Yahoo
Church & Dwight Co., Inc. Issues Voluntary Nationwide Recall of Zicam® Cold Remedy Nasal Swabs, Zicam® Nasal AllClear Swabs, and Orajel™ Baby Teething Swabs Due to Microbial Contamination
EWING, N.J., June 6, 2025 /PRNewswire/ -- Church & Dwight Co., Inc. is voluntarily recalling all lots within expiry of Zicam® Cold Remedy Nasal Swabs, Zicam® Nasal AllClear Swabs, and Orajel™ Baby Teething Swabs to the consumer level. The products are being recalled due to potential microbial contamination identified as fungi in cotton swab components. Swabs found to contain microbial contamination can potentially present a significant risk to the health and safety of consumers including serious and life-threatening blood infections in users whose nasal mucosa may be compromised due to inflammation and mechanical injuries. The risk is highest (potentially severe or life-threatening) among children and individuals with compromised immune systems or other underlying medical conditions. To date, no serious adverse events associated with the affected product have been reported. The recalled products were distributed nationwide in the United States and in Puerto Rico. Recalled Product Information Zicam® Cold Remedy Nasal Swabs, with UPC 732216301205, all lots: A zinc-free, homeopathic cold remedy swab designed to shorten the duration of the common cold. Zicam® Nasal AllClear Swabs, with UPC 732216301656, all lots: A nasal cleansing swab product (discontinued in December 2024). Orajel™ Baby Teething Swabs, with UPC 310310400002, all lots: Pre-moistened swabs designed to soothe teething discomfort in infants and toddlers. What Consumers Should Do Consumers who have purchased any of the recalled products should stop using the product immediately. Please visit or call its Consumer Relations team at (800) 981-4710 for a full refund. Any additional questions can also be directed to its Consumer Relations team Monday through Friday, 9am – 5pm ET. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online: Regular Mail or Fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. This recall is limited exclusively to Zicam and Orajel swab products. All other Zicam and Orajel products, including Zicam RapidMelts, are not affected by this recall. About Church & Dwight Co., Inc. Church & Dwight Co., Inc. is a leading manufacturer of consumer household and personal care products. For more information, visit Media Contact:Keith View original content to download multimedia: SOURCE Church & Dwight Co. Sign in to access your portfolio
